We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LYG:NYSELloyds Banking Group Plc Analysis

Data as of 2026-04-16 - not real-time

$5.61

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Lloyds Banking Group (LYG) is trading at $5.61, comfortably above its 20‑day ($5.21), 50‑day ($5.43) and 200‑day ($4.91) simple moving averages, indicating a short‑term price bias to the upside. The RSI of 61.9 and a bullish MACD histogram reinforce momentum, while the stock remains within a neutral trend envelope between a support of $4.81 and resistance of $5.70. Valuation metrics are attractive – a trailing P/E of 15.2 sits below the industry average of 17.6 and a forward P/E of 10.5 suggests earnings growth ahead. The dividend yield of 3.56% with a payout ratio under 50% adds income appeal, and analyst consensus has recently upgraded to Buy with an average price target of $6.42, implying roughly 14% upside versus the model’s 5.2% upside estimate. Short interest has risen sharply but remains modest at 0.17% of float, meaning less than a day’s trading volume would cover shorts, limiting downside pressure.
The balance sheet shows abundant cash ($171 bn) offset by high debt ($148 bn), yet the debt‑to‑equity ratio is reported as zero, reflecting strong capital adequacy. Operating cash flow is negative, a caution flag, but the firm’s dividend sustainability appears intact given the cash cushion and modest payout. Volatility is elevated at 37.7% over the past 30 days, though beta near 1 indicates market‑aligned risk. Liquidity is slightly constrained as volume trends downward, but market cap remains robust at $82 bn.
Overall, LYG presents an undervalued, income‑focused play with modest upside potential in the near term, balanced by sector‑specific regulatory and geographic exposures that warrant a measured stance for longer horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above all major SMAs and bullish MACD signal
  • Recent analyst upgrade to Buy with 14% upside target
  • Strong dividend yield and low short‑interest coverage

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued valuation relative to peers (P/E below industry)
  • Sustainable dividend providing income buffer
  • Moderate volatility and sector‑specific regulatory environment

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable cash generation capacity despite negative operating cash flow
  • Exposure to UK economic cycles and regulatory changes
  • High debt levels offset by large cash reserves and solid capital ratios

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin25.01%
P/E Ratio15.2
ROE10.15%
ROA0.51%
P/B Ratio6.0
Op. Cash Flow$-7781000192
Industry P/E17.6

Technical Analysis

TrendNeutral
RSI61.9
Support$4.81
Resistance$5.70
MA 20$5.21
MA 50$5.43
MA 200$4.91
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Target Price$5.90
Upside/Downside5.23%
GradeUndervalued
TypeBlend
Dividend Yield3.56%

Risk Assessment

Beta0.97
Volatility37.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.